Market Place
Sourcing Support
Curi Bio and Cook MyoSite Announce Strategic Partnership
30 Apr 2025 //
BUSINESSWIRE
Curi Bio Opens New Global Headquarters in Seattle
08 Apr 2025 //
BUSINESSWIRE
Curi Bio Unlocks Cardiac Insights with Novoheart Integration
19 Dec 2024 //
BUSINESSWIRE
Curi Bio Recognized as a 2024 Deloitte Technology Fast 500 Winner
22 Nov 2024 //
BUSINESSWIRE
Following growth, Curi Bio expands into larger Seattle lab space
27 Aug 2024 //
FIERCE BIOTECH
Curi Bio Moves To New Seattle Location For Drug Discovery Research
22 Aug 2024 //
BUSINESSWIRE
Curi Bio, Genetox, and DreamCIS Sign MOU for Strategic Collaboration
22 Feb 2024 //
BUSINESSWIRE
Curi Bio Launches Nautilus and Stingray Platforms for Translational Research
18 Sep 2023 //
BUSINESSWIRE
Curi Bio Launches MantaReady™ 3D Skeletal Muscle Tissue Media
14 Mar 2023 //
BUSINESSWIRE
Curi Bio Names Nicholas A. Geisse, Ph.D., as New Chief Executive Officer
14 Feb 2023 //
BUSINESSWIRE
Curi Bio Names Nicholas Geisse CEO
14 Feb 2023 //
CONTRACT PHARMA
Curi Bio Launches Mantarray Platform for Discovery of New Therapeutics
27 Jul 2022 //
BUSINESSWIRE
Curi Bio Acquires CarTox Technology from StemBioSys, Launches Nautilus
29 Mar 2022 //
BUSINESSWIRE
Curi Bio and NEXEL`s JV Celogics, to Develop iPSC-derived Cell Products
26 Oct 2021 //
BUSINESSWIRE
Curi Bio Raises $6M Series A Financing Round for iPSC-derived Platforms
19 Mar 2021 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.